Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Novo Nordisk Says It Will Slash the Price of Insulin

The New York Times – Business:

The company’s decision follows a similar move by its rival, Eli Lilly, this month.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Drugs (Pharmaceuticals), Eli Lilly and Company, Insulin, Novo Nordisk A/S, Prices (Fares, Fees and Rates)
←Republicans Pitch Cuts To Federal Food Benefits
AI Funding Frenzy Escalates→

More posts

  • Bob Iger’s New Magic Kingdom: Fans & Media Wonder If He Can Bring That Disney Sparkle To The Lakers

  • Photos: See the best photos from the solar eclipse

  • Ebola outbreak on track to be deadliest ever, WHO chief says

  • Jeremy Strong Emailed Mark Zuckerberg To Assure Him He Takes ‘The Social Reckoning’ Role “Very Seriously”

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube